Avitide Receives Series D Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    16 Cavendish Court Lebanon, NH 03766 USA
  • Company Description
    Avitide develops customized biopharmaceutical affinity purification products with an industry-leading discovery and development service time
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds from this financing will allow us broaden and deepen existing relationships, embark on new strategic initiatives, and support our growing roster of partnered programs and novel affinity separation products,” said Kevin Isett, CEO and Co-Founder of Avitide.
  • M&A Terms
  • Venture Investor
    Mithril Capital Management
  • Venture Investor

Trending on Xconomy